| Record ID | marc_columbia/Columbia-extract-20221130-016.mrc:170623576:3094 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-016.mrc:170623576:3094?format=raw |
LEADER: 03094cam a2200613 a 4500
001 7950701
005 20221201045701.0
008 080910t20092009nyua b 001 0 eng
010 $a 2008039796
016 7 $a101483886$2DNLM
019 $a226356707
020 $a9780073380797 (alk. paper)
020 $a0073380792 (alk. paper)
029 1 $aNLM$b101483886
029 1 $aAU@$b000043702934
029 1 $aNZ1$b13202795
035 $a(OCoLC)ocn248348338
035 $a(NNC)7950701
035 $a(OCoLC)248348338$z(OCoLC)226356707
035 $a7950701
040 $aDNLM/DLC$cDLC$dBTCTA$dBAKER$dNLM$dCDX$dHF9$dYDXCP$dMUQ
042 $apcc
050 00 $aRM316$b.R39 2009
060 00 $a2010 I-171
060 10 $aQV 77$bH325d 2009
082 00 $a615/.78$222
100 1 $aHart, Carl L.$0http://id.loc.gov/authorities/names/n2005020200
245 10 $aDrugs, society, and human behavior /$cCarl Hart, Charles Ksir, Oakley Ray.
250 $a13th ed.
260 $aNew York, NY :$bMcGraw-Hill,$c[2009], ©2009.
300 $axx, 482 pages :$billustrations (some color) ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aCharles Ksir's name appears first on the earlier ed.
504 $aIncludes bibliographical references and index.
505 0 $aDrug use : an overview -- Drug use as a social problem -- Drug products and their regulations -- The nervous system -- The actions of drugs -- Stimulants -- Depressants and inhalants -- Medication for mental disorders -- Alcohol -- Tobacco -- Caffeine -- Dietary supplements -- Opioids -- Hallucinogens -- Marijuana -- Performance-enhancing drugs -- Preventing substance abuse -- Treating substance abuse and dependence.
650 0 $aPsychotropic drugs.$0http://id.loc.gov/authorities/subjects/sh85108528
650 0 $aDrug abuse.$0http://id.loc.gov/authorities/subjects/sh85039675
650 0 $aDrug abuse$xSocial aspects.$0http://id.loc.gov/authorities/subjects/sh85039682
650 0 $aNeuropsychopharmacology.$0http://id.loc.gov/authorities/subjects/sh85091165
650 6 $aPsychotropes.
650 6 $aToxicomanie.
650 6 $aToxicomanie$xAspect social.
650 6 $aNeuropsychopharmacologie.
650 12 $aBehavior$xdrug effects.$0https://id.nlm.nih.gov/mesh/D001519Q000187
650 12 $aPsychopharmacology.$0https://id.nlm.nih.gov/mesh/D011600
650 22 $aCentral Nervous System Agents$xadverse effects.$0https://id.nlm.nih.gov/mesh/D002491Q000009
650 22 $aCentral Nervous System Agents$xpharmacokinetics.$0https://id.nlm.nih.gov/mesh/D002491Q000493
650 22 $aSocial Problems$xprevention & control.$0https://id.nlm.nih.gov/mesh/D012940Q000517
650 22 $aSubstance-Related Disorders$xprevention & control.$0https://id.nlm.nih.gov/mesh/D019966Q000517
700 1 $aKsir, Charles.$0http://id.loc.gov/authorities/names/n85348093
700 1 $aRay, Oakley Stern.$0http://id.loc.gov/authorities/names/n82075755
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0828/2008039796.html
852 00 $bsci$hRM316$i.R39 2009